Essential, orthopaedic-specific, strategic updates like these, direct to your inbox.
Zimmer completed its acquisition of Biomet in a cash and equity transaction valued at ~US $14BB. The new corporate entity, Zimmer Biomet, will trade on NYSE and the Swiss Exchange as ZBH beginning 6/29/15.
Zimmer (ZMH) agreed to divest U.S. rights and assets for the ZUK unicondylar knee to Smith & Nephew (SNN), and U.S. rights and assets for Biomet’s Discovery Total Elbow and Cobalt Bone Cement to DJO Global. The SNN transaction will close within 3 business days following closure of the ZMH/Biomet merger.
ConforMIS set terms for its IPO, offering 9MM shares at a price range of $14 to $16. The company expects to submit an application to FDA for clearance of the iTotal customized hip in 2015.
Aesculap Implant Systems received FDA approval to market the activL® Artificial Disc for treatment of 1-level lumbar degenerative disc disease.
ORTHOFLASH is included with Membership. Click here to learn more.
Not ready to buy? Try it for a month.
Click the orange button above to add the "1 month/$39" to your cart, and when you reach the check-out page, enter promo code "WEBSITE" and complete the process.
Your complimentary month of ORTHOFLASH will begin right away! As a subscriber, you can expect to receive 1-3 ORTHOFLASH emails per business day.
Still have questions? Or, would you prefer personal attention? Fran Bursic welcomes your inquiry by phone at 440.543.2101 or via email.